by International Association for Dental, Oral, and Craniofacial ResearchCredit: Pixabay/CC0 Public DomainA study investigating the effects of local application of fibroblast growth factor (FGF-2) on p
by International Association for Dental, Oral, and Craniofacial ResearchCredit: Pixabay/CC0 Public DomainA study investigating the effects of local application of fibroblast growth factor (FGF-2) on p
byCedars-Sinai Medical CenterTix-Cil dosing and infections during the study period. The frequency and timing of Tix-Cil dosing and SARS-CoV-2 infections occurring in the study cohort is shown in
byCedars-Sinai Medical CenterTix-Cil dosing and infections during the study period. The frequency and timing of Tix-Cil dosing and SARS-CoV-2 infections occurring in the study cohort is shown in
by Shibaura Institute of TechnologyDietary uptake of polyphenols alters the gut microflora and stimulates the secretion of specific hormones that induce cross-talk with the brain via the sensory
by Shibaura Institute of TechnologyDietary uptake of polyphenols alters the gut microflora and stimulates the secretion of specific hormones that induce cross-talk with the brain via the sensory
byUniversity of TokyoGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113420Pancreatic ductal adenocarcinoma (PDAC), that arises from pancreatic epithelial c
byUniversity of TokyoGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113420Pancreatic ductal adenocarcinoma (PDAC), that arises from pancreatic epithelial c
by King's College LondonCredit: Pixabay/CC0 Public DomainA key mechanism controlling how bone marrow stem cells work has been revealed in a new study, shining a light on the principles of ste
by King's College LondonCredit: Pixabay/CC0 Public DomainA key mechanism controlling how bone marrow stem cells work has been revealed in a new study, shining a light on the principles of ste
by Pennington Biomedical Research CenterChristopher Axelrod, Director, Integrated Physiology and Molecular Medicine Laboratory at Pennington Biomedical Research Center. Credit: PBRCA newstudy&nb
by Pennington Biomedical Research CenterChristopher Axelrod, Director, Integrated Physiology and Molecular Medicine Laboratory at Pennington Biomedical Research Center. Credit: PBRCA newstudy&nb
byLudwig Maximilian University of MunichSchematic of the experimental design; PBMCs, peripheral blood mononuclear cells. Credit:Nature Immunology(2023). DOI: 10.1038/s41590-023-01656
byLudwig Maximilian University of MunichSchematic of the experimental design; PBMCs, peripheral blood mononuclear cells. Credit:Nature Immunology(2023). DOI: 10.1038/s41590-023-01656
by Ina Wittmann,Max Planck SocietyThe analysis of Beethoven's DNA shows possibilities and limits of predictions in the field of genetics. Credit: MPIEA / F. BernoullyTo what extent are excep
by Ina Wittmann,Max Planck SocietyThe analysis of Beethoven's DNA shows possibilities and limits of predictions in the field of genetics. Credit: MPIEA / F. BernoullyTo what extent are excep
JANUARY 24, 2024by Gillian Rutherford,University of AlbertaCredit: Pixabay/CC0 Public DomainA University of Alberta research team has uncovered differences in the way male and female mice develo
JANUARY 24, 2024by Gillian Rutherford,University of AlbertaCredit: Pixabay/CC0 Public DomainA University of Alberta research team has uncovered differences in the way male and female mice develo
FEBRUARY 6, 2024byIndiana University School of MedicineOverview of experimental study design employed to examine the utility of using ChatGPT to write scientific review articles about the inters
FEBRUARY 6, 2024byIndiana University School of MedicineOverview of experimental study design employed to examine the utility of using ChatGPT to write scientific review articles about the inters
by Elana GotkineFor heavily transfused patients with lower-risk myelodysplastic syndromes (LR-MDS) who are not responding to or are ineligible for erythropoiesis-stimulating agents (ESAs), the competi
by Elana GotkineFor heavily transfused patients with lower-risk myelodysplastic syndromes (LR-MDS) who are not responding to or are ineligible for erythropoiesis-stimulating agents (ESAs), the competi